A molecular mechanism for angiotensin II receptor blocker‐mediated slit membrane protection: Angiotensin II increases nephrin endocytosis via AT1 ‐receptor‐dependent ERK 1/2 activation
The FASEB Journal · 2024
DOI: 10.1096/fj.202400369r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Eva Königshausen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Medical School Duesseldorf, Heinrich Heine University, Duesseldorf, Germany. Hauptthemen laut MEDLINE: Endocytosis, Membrane Proteins, Angiotensin II, Receptor, Angiotensin, Type 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Albuminuria is characterized by a disruption of the glomerular filtration barrier, which is composed of the fenestrated endothelium, the glomerular basement membrane, and the slit diaphragm. Nephrin is a major component of the slit diaphragm. Apart from hemodynamic effects, Ang II enhances albuminuria by β‐Arrestin2‐mediated nephrin endocytosis. Blocking the AT1 receptor with candesartan and irbesartan reduces the Ang II‐mediated nephrin‐β‐Arrestin2 interaction. The inhibition of MAPK ERK 1/2 blocks Ang II‐enhanced nephrin‐β‐Arrestin2 binding. ERK 1/2 signaling, which follows AT1 receptor activation, is mediated by G‐protein signaling, EGFR transactivation, and β‐Arrestin2 recruitment. A mutant AT1 receptor defective in EGFR transactivation and β‐Arrestin2 recruitment reduces the Ang II‐mediated increase in nephrin β‐Arrestin2 binding. The mutation of β‐Arrestin2 K11,K12 , critical for AT1 receptor binding, completely abrogates the interaction with nephrin, independent of Ang II stimulation. β‐Arrestin2 K11R,K12R does not influence nephrin cell surface expression. The data presented here deepen our molecular understanding of a blood‐pressure‐independent molecular mechanism of AT‐1 receptor blockers (ARBs) in reducing albuminuria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Medical School Duesseldorf, Heinrich Heine University, Duesseldorf, Germany.
ORCID-Profile: Eva Königshausen, Ulf M Zierhut, Martin Ruetze, Lars C Rump, Lorenz Sellin
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Königshausen, E., Zierhut, U. M., Ruetze, M., Rump, L. C., & Sellin, L. (2024). A molecular mechanism for angiotensin II receptor blocker‐mediated slit membrane protection: Angiotensin II increases nephrin endocytosis via AT1 ‐receptor‐dependent ERK 1/2 activation. The FASEB Journal. https://doi.org/10.1096/fj.202400369r
Vancouver
Königshausen E, Zierhut UM, Ruetze M, Rump LC, Sellin L. A molecular mechanism for angiotensin II receptor blocker‐mediated slit membrane protection: Angiotensin II increases nephrin endocytosis via AT1 ‐receptor‐dependent ERK 1/2 activation. The FASEB Journal. 2024. doi:10.1096/fj.202400369r
BibTeX
@article{Knigshausen2024,
author = {Königshausen, Eva and Zierhut, Ulf M and Ruetze, Martin and Rump, Lars C and Sellin, Lorenz},
title = {A molecular mechanism for angiotensin II receptor blocker‐mediated slit membrane protection: Angiotensin II increases nephrin endocytosis via AT1 ‐receptor‐dependent ERK 1/2 activation},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400369r}
}
EUVIMED